Anti-obesity effects of tea from Mangifera indica L. leaves of the Ubá variety in high-fat diet-induced obese rats

Biomedicine and Pharmacotherapy

Volumn 91, Issue , 2017, Pages 938-945

  Ramírez, Natalia Medina ^a   Toledo, Renata C Lopes ^a   Moreira, Maria E Castro ^a   Martino, Hércia Stampini Duarte ^a   Benjamin, Laércio dos Anjos ^a   de Queiroz, José H ^a   Ribeiro, Andréia Queiroz ^a   Ribeiro, Sônia Machado Rocha ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Adipogenesis; Gene modulation; Inflammation; Mango; Oxidative stress

Indexed keywords

ANTIOBESITY AGENT; BIOLOGICAL MARKER; FATTY ACID SYNTHASE; INTERLEUKIN 10; LIPOPROTEIN LIPASE; MANGIFERA INDICA EXTRACT; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT;

ABDOMINAL FAT; ADIPOGENESIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIET INDUCED OBESITY; INFLAMMATION; INTRAPERITONEAL FAT; MALE; MANGO; MEDICINAL PLANT; METABOLIC REGULATION; MORPHOMETRY; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; PRIORITY JOURNAL; RAT; TEA; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; DIETARY SUPPLEMENT; DRUG EFFECTS; LIPID DIET; MANGIFERA; METABOLISM; OBESITY; PHYTOTHERAPY; PROCEDURES; WISTAR RAT;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; INFLAMMATION; INTERLEUKIN-10; MALE; MANGIFERA; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PPAR GAMMA; RATS; RATS, WISTAR; TEA;

EID: 85019150115     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.015     Document Type: Article

References (57)

1. Caballero, B., The global epidemic of obesity: an overview. Epidemiol. Rev. 29 (2007), 1–5.
2. Lim, J., Liu, Z., Apontes, P., Feng, D., Pessin, J.E., Sauve, A.A., Angeletti, R.H., Chi, Y., Dual mode action of mangiferin in mouse liver under high fat diet. PLoS One, 9(3), 2014, e90137.
3. Hongli, G., Zhaochun, L., Xiaolan, Q., Ying, Z., Effects of Yerba Mate tea (Ilex paraguariensis) on vascular endothelial function and liver lipoprotein receptor gene expression in hyperlipidemic rats. Fitoterapia, Elsevier 84 (2012), 264–272.
4. Jobu, K., Yokota, J., Yoshioka, S., Moriyama, H., Murata, S., Ohishi, M., Ukeda, H., Miyamura, M., Effects of Goishi tea on diet-induced obesity in mice. Food Res. Int., Elsevier 54 (2013), 324–329.
5. Chan, C.Y., Wei, L., Castro-Munozledo, F., Koo, W.L., (−)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression. Life Sci. 89:21–22 (2011), 779–785.
6. Friedrich, M., Petzke, K.J., Raederstorff, D., Wolfram, S., Klaus, S., Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet. Int. J. Obes. 36:5 (2005), 35–43 (2012).
7. Nagao, T., Hase, T., Tokimitsu, I., A green tea extract high in catechins reduces body fat and cardiovascular risks in humans, Obesity (Silver Spring. Obesity (Silver Spring, Md.) 15:6 (2007), 1473–1483.
8. Basu, A., Sanchez, K., Leyva, M.J., Wu, M., Betts, N.M., Aston, C.E., Lyons, T.J., Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 29:1 (2010), 31–40.
9. Choo, J.J., Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J. Nutr. Biochem. 14:11 (2003), 671–676.
10. Cao, Y., Bao, S., Yang, W., Zhang, J., Li, L., Shan, Z., Teng, W., Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr. Res. (New York, N.Y.) 34:12 (2014), 1066–1074.
11. Wang, H., Wen, Y., Du, Y., Yan, X., Guo, H., Rycroft, J.A., Boon, N., Kovacs, E.M., Mela, D.J., Effects of catechin enriched green tea on body composition. Obesity (Silver Spring, Md.) 18:4 (2010), 773–779.
12. Kim, H., Sakamoto, K., (−)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3 K/Akt pathways. Cell Biol. Int. 36:2 (2012), 147–153.
13. Hursel, R., Westerterp-Plantenga, M.S., Catechin- and caffeine-rich teas for control of body weight in humans. Am. J. Clin. Nutr. 98:Suppl. 6 (2013), 1682–1693.
14. Vazquez-Prieto, M.A., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (−)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 527:2 (2012), 113–118.
15. Xiao, J., Ho, C.T., Liong, E.C., Nanji, A.A., Leung, T.M., Lau, T.Y.H., Fung, M.L., Tipoe, G.L., Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur. J. Nutr. 53:1 (2013), 187–199.
16. Ponce, M.T.F., Casas, L., Mantell, C., Rodríguez, M., Martínez de la Ossa, E., Extraction of antioxidant compounds from different varieties of Mangifera indica leaves using green technologies. J. Supercrit. Fluids 72 (2012), 168–175.
17. Kulkarni, V.M., Rathod, V.K., Extraction of mangiferin from Mangifera indica leaves using threephase partitioning coupled with ultrasound. Ind. Crops Prod. 52 (2014), 292–297.
18. Guo, F., Huang, C., Liao, X., Wang, Y., He, Y., Feng, R., Li, Y., Sun, C., Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol. Nutr. Food Res. 55:12 (2011), 1809–1818.
19. Niu, Y., Li, S., Na, L., Feng, R., Liu, L., Li, Y., Sun, C., Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK. PLoS One, 7(1), 2012, e30782.
20. McLendon, A.N., Spivey, J., Woodis, C.B., African mango (Irvingia gabonensis) Extract for weight loss: a systematic review. J. Nutr. Disord. Ther. 2:1 (2013), 53–58.
21. Benard, O., Chi, Y., Medicinal properties of mangiferin, structural features, derivative synthesis, pharmacokinetics and biological activities. Mini Rev. Med. Chem. 15:7 (2015), 582–594.
22. Luo, F., Fu, Y., Xiang, Y., Yan, S., Hu, G., Huang, X., Huang, G., Sun, C., Li, X., Chen, K., Identification and quantification of gallotannins in mango (Mangifera indica L.) kernel and peel and their antiproliferative activities. J. Funct. Foods 8:0 (2014), 282–291.
23. Palafox, E.M., Identification and quantification of major phenolic compounds from mango (Mangifera indica, cv. Ataulfo) fruit by HPLC–DAD–MS/MS-ESI and their individual contribution to the antioxidant activity during ripening. Food Chem. 135:1 (2017), 105–111 (2012).
24. Ribeiro, S.M.R., Barbosa, L.C.A., Queiroz, J.H., Knödler, M., Schieber, A., Phenolic compounds and antioxidant capacity of Brazilian mango (Mangifera indica L.) varieties. Food Chem. 110:3 (2008), 620–626.
25. Medina Ramírez, N., Monteiro Farias, L., Apolonio Santana, F., Viana Leite, J., De Souza Dantas, M., Lopes Toledo, R., De Queiroz, J., Stampini Duarte Martino, H., Machado Rocha Ribeiro, S., Extraction of mangiferin and chemical characterization and sensorial analysis of teas from mangifera indica L. leaves of the ubá variety. Beverages, 2(4), 2016, 33.
26. ®, Open Formula Purified Diets for Lab Animals – D12079B OPEN SOURCE DIETS. 2006.
27. Novelli, E.L., Diniz, Y.S., Galhardi, C.M., Ebaid, G.M., Rodrigues, H.G., Mani, F., Fernandes, A.A., Cicogna, A.C., Novelli, L.V., Anthropometrical parameters and markers of obesity in rats. Lab. Anim. 41 (2007), 111–119.
28. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
29. Galarraga, M., Campion, J., Munoz-Barrutia, A., Boque, N., Moreno, H., Martinez, J.A., Milagro, F., Ortiz-de-Solorzano, C., Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. J. Lipid Res. 53:12 (2012), 2791–2796.
30. Agranonik, M., Hirakata, V.N., Cálculo de tamanho de amostra: proporções, 31(3), 2011, 2011.
31. Matthews, J.N., Altman, D.G., Campbell, M.J., Royston, P., Analysis of serial measurements in medical research. BMJ (Clin. Res. ed.) 300:6719 (1990), 230–235.
32. Johnson, R.J., Lanaspa, M.A., Gaucher, E.A., Uric acid a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Semin. Nephrol. 31:5 (2011), 394–399.
33. Killard, A.J., Smyth, M.R., Creatinine biosensors: principles and designs. Trends Biotechnol. 18:10 (2000), 433–437.
34. Pundir, C.S., Yadav, S., Kumar, A., Creatinine sensors. TrAC Trends Anal. Chem. 50 (2013), 42–52.
35. Wedemeyer, H., Hofmann, W.P., Lueth, S., Mallnski, P., Thimme, R., Tacke, F., Wiegand, J., ALT screening for chronic liver diseases: scrutinizing the evidence. Z. Gastroenterol. 48:1 (2010), 46–55.
36. Osei, K., Rhinesmith, S., Gaillard, T., Schuster, D., Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 27:6 (2004), 1439–1446.
37. Song, Y., Manson, J.A.E., Tinker, L., Howard, B.V., Kuller, L.H., Nathan, L., Rifai, N., Liu, S., Insulin sensitivity and insulin secretion determined by homeostasis model assessment (HOMA) and risk of diabetes in a multiethnic cohort of women: the women's health initiative observational study. Diabetes Care 30:7 (2007), 1747–1752.
38. Garg, M.K., Dutta, M.K., Mahalle, N., Study of beta-cell function (by HOMA model) in metabolic syndrome. Indian J. Endocrinol. Metab. 15:Suppl. 1 (2011), S44–S49.
39. Dandona, P., Aljada, A., Bandyopadhyay, A., Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25:1 (2004), 4–7.
40. Leon-Cabrera, S., Arana-Lechuga, Y., Esqueda-Le, rez, G., Gonzalez-Chavez, A., Escobedo, G., zquez Moctezuma, J., Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators Inflamm., 2015, 2015, 9.
41. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29:1 (2011), 415–445.
42. Akdis, C.A., Blaser, K., Mechanisms of interleukin-10-mediated immune suppression. Immunology 103:2 (2001), 131–136.
43. Hong, E.G., Ko, H.J., Cho, Y.R., Kim, H.J., Ma, Z., Yu, T.Y., Friedline, R.H., Kurt-Jones, E., Finberg, R., Fischer, M.A., Granger, E.L., Norbury, C.C., Hauschka, S.D., Philbrick, W.M., Lee, C.G., Elias, J.A., Kim, J.K., Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58:11 (2009), 2525–2535.
44. Keane, K.N., Cruzat, V.F., Carlessi, R., de Bittencourt, P.I.H., Newsholme, P., Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid. Med. Cell. Longevity, 2015, 2015.
45. Avram, M.M., Sharpe, A., James, W.D., Subcutaneous fat in normal and diseased states: 3. Adipogenesis: from stem cell to fat cell. J. Am. Acad. Dermatol. 56:3 (2007), 472–492.
46. Ferranti, S., Mozaffarian, D., La tormenta perfecta: obesidad, disfunción del adipocito y consecuencias metabólicas. Clin. Chem. 34:2 (2009), 95–108.
47. Desarzens, S., Liao, W.H., Mammi, C., Caprio, M., Faresse, N., Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation. PLoS One, 9(4), 2014, e94127.
48. Zhou, X., Han, D., Xu, R., Li, S., Wu, H., Qu, C., Wang, F., Wang, X., Zhao, Y., A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. PLoS One, 9(12), 2014, e115148.
49. Rosen, E.D., Spiegelman, B.M., Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16:1 (2000), 145–171.
50. White, U.A., Stephens, J.M., Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 318:1–2 (2010), 10–14.
51. Berndt, J., Kovacs, P., Ruschke, K., Klöting, N., Fasshauer, M., Schön, M., Körner, A., Stumvoll, M., Blüher, M., Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50:7 (2007), 1472–1480.
52. Guichard, C., Dugail, I., Le Liepvre, X., Lavau, M., Genetic regulation of fatty acid synthetase expression in adipose tissue: overtranscription of the gene in genetically obese rats. J. Lipid Res. 33:5 (1992), 679–687.
53. Loftus, T.M., Jaworsky, D.E., Frehywot, G.L., Townsend, C.A., Ronnett, G.V., Lane, M.D., Kuhajda, F.P., Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:5475 (2000), 2379–2381.
54. Liang, Y., Tian, W., Ma, X., Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase. BMC Complement. Altern. Med., 13(1), 2013, 1.
55. Wang, H., Eckel, R.H., Lipoprotein lipase: from gene to obesity. Am. J. Physiol.-Endocrinol. Metab. 297:2 (2009), E271–E288.
56. Walton, R.G., Zhu, B., Unal, R., Spencer, M., Sunkara, M., Morris, A.J., Charnigo, R., Katz, W.S., Daugherty, A., Howatt, D.A., Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity. J. Biol. Chem. 290:18 (2015), 11547–11556.
57. Herranz-López, M., Barrajón-Catalán, E., Segura-Carretero, A., Menéndez, J.A., Joven, J., Micol, V., Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms. Phytomedicine 22:6 (2015), 605–614.